Linde plc filings document an Irish public company's industrial gases and engineering business, Nasdaq-listed ordinary shares, operating results and capital-structure activity. Results 8-Ks furnish quarterly and annual financial releases covering sales, operating profit, cash flow, capital expenditures, dividends and stock repurchases for a business serving chemicals and energy, food and beverage, electronics, healthcare, manufacturing, metals and mining.
Governance filings include definitive proxy materials, annual general meeting voting results, board elections, executive compensation and leadership changes. Other 8-K disclosures record euro note issuances under Linde's European debt issuance programme and related use of proceeds for general corporate purposes.
Linde plc Chief Financial Officer Matthew J. White exercised options for 228,175 ordinary shares on November 4, 2026, in four tranches at exercise prices of $118.71, $154, $173.13 and $176.63 per share. The transactions also included 141,342 shares delivered or withheld for payment of exercise price or tax liability and sales of 86,833 shares across four transactions at $524.25, $518.50, $520 and $525 per share. Other listed positions include 3,096 ordinary shares through a 401(k), 72,795 options at $118.71 expiring February 28, 2027, and 2,728 restricted stock units.
Linde plc Executive Vice President and Chief Legal Officer Guillermo Bichara exercised options for 26,155 ordinary shares on November 2, 2026, at an exercise price of $173.13 per share. The same-day transactions also included 16,805 shares withheld for the exercise price and tax withholdings and a sale of 9,350 shares at a weighted average price of $518.911 per share. No Rule 10b5-1 plan is reported. Remaining option positions include 40,100 shares exercisable at $118.71, expiring February 28, 2027, and 38,800 at $154.00, expiring February 27, 2028.
Linde plc is named in a Form 144 listing 86,833 common shares for sale, with an aggregate market value of $45,258,063.00 and November 4, 2026 as the approximate sale date. The person identified for whose account the shares are to be sold is Matthew J. White, an officer; remarks say the sale occurred in the Matthew J. White Trust Agreement, where he is trustee and account stakeholder. Daniel Tucci signed as Fidelity Brokerage Services LLC's duly authorized representative and attorney-in-fact for Matthew White.
Linde plc officer Guillermo Bichara reported a proposed sale of 9,350 common shares, with an aggregate market value of $4,851,825.79 and an approximate sale date of November 2, 2026, through Fidelity Brokerage Services LLC. The shares are described as acquired from the issuer through a stock option exercise on November 2, 2026, with cash as the payment method. Linde plc had 459,083,779 common shares outstanding.
Linde plc reported third-quarter 2026 sales of $9.404 billion, up 9% from $8.615 billion a year earlier. Reported operating profit fell 9% to $2.150 billion, net income attributable to Linde plc fell 12% to $1.692 billion, and diluted earnings per share declined 11% to $3.66. The quarter included $425 million in cost reduction and other charges. On an adjusted, non-GAAP basis, operating profit rose 8% to $2.763 billion and diluted EPS rose 9% to $4.59.
For the first nine months, sales increased 9% to $27.474 billion, while net income attributable to Linde plc increased 2% to $5.477 billion and adjusted diluted EPS increased 9% to $13.41. Operating cash flow rose 5% to $7.680 billion; capital expenditures were $4.172 billion. Dividends paid totaled $2.214 billion, and the quarterly dividend per share was $1.60 versus $1.50 a year earlier. At September 30, 2026, cash and cash equivalents were $3.947 billion and total debt was $26.702 billion.
Linde plc (LIN) reported third-quarter 2026 sales of $9.404 billion, up 9% year over year, including a 1% favorable currency impact; underlying sales rose 5%. Net income was $1.692 billion, down 12%, and diluted EPS was $3.66, down 11%. Adjusted net income rose 7% to $2.122 billion, while adjusted diluted EPS rose 9% to $4.59.
Adjusted operating profit increased 8% to $2.763 billion, with a 29.4% adjusted operating profit margin. Operating cash flow was $3.169 billion, up 8%; after $1.392 billion in capital expenditures, free cash flow was $1.777 billion. Linde returned $1.685 billion to shareholders through dividends and stock repurchases, net of issuances. Project backlog was $11 billion.
Linde expects fourth-quarter adjusted diluted EPS of $4.40 to $4.50, up 5% to 7% versus the prior-year quarter. Full-year 2026 adjusted diluted EPS guidance is $17.82 to $17.92, representing 8% to 9% growth assuming favorable currency of 2% versus prior year. Full-year capital expenditures are expected to range from $5.5 billion to $6.0 billion.
Linde plc (LIN) reports that Armando Botello, Senior VP, APAC, directly held 4,817 ordinary shares as of October 1, 2026. He also held three restricted-stock-unit awards covering 170, 244 and 168 ordinary shares, scheduled to vest in full and pay out on or about March 7, 2027, March 9, 2029 and March 7, 2028, respectively. His direct option positions include 3,460 shares at an exercise price of 154.00, expiring February 27, 2028, and 1,989 shares at 483.62, expiring March 9, 2036.
Linde plc director Paula Rosput Reynolds acquired 18.106 deferred stock units on October 1, 2026, under the Linde Non-Employee Director Deferral Plan. The units pay out in ordinary shares on a one-for-one basis, and her reported deferred stock unit balance after the acquisition was 162.924. The report also lists 473 ordinary shares underlying fully vested RSUs with payout deferred, and a separate 476-share RSU award that vests one year after its March 9, 2026 grant, subject to continuous board service; its payout is deferred until board service ends.
Linde plc director Hugh Grant acquired 72.425 deferred stock units on October 1, 2026, under the Linde Non-Employee Director Deferral Plan. The units convert one-for-one into ordinary shares and are payable upon termination of director service; his reported post-transaction balance was 651.700 deferred stock units. His reported holdings also include 473.148 fully vested restricted stock units and 476.009 restricted stock units, corresponding to underlying ordinary shares, plus 1,082 direct ordinary shares.
LINDE PLC (LIN) director Paula Rosput Reynolds reported buying 100 Ordinary Shares on 2026-08-18 in an open-market or private transaction at $479.115 per share, increasing her direct share position. She also reports direct holdings of Deferred Stock Units and multiple Restricted Stock Unit awards, each convertible into Linde ordinary shares on a 1-for-1 basis, some fully vested with payout deferred under company director compensation plans.